0.27 0.00(0.00%) May 23, 2:03PM EDT
4535 Wilfrid-Hamel Boulevard
Quebec, QC G1P 2J7
Canada - Map
DiagnoCure, Inc., a life sciences company, engages in the development and commercialization of cancer diagnostic tests for the detection and management of cancer. The company primarily focuses on molecular diagnostic tests. It has granted a worldwide exclusive license agreement to Gen-Probe for the development and commercialization of a prostate cancer test using PCA3. The company was founded in 1994 and is headquartered in Quebec, Canada.